A new score based on the PEGASUS-TIMI 54 criteria for risk stratification of patients with acute myocardial infarction

被引:9
|
作者
Cosentino, Nicola [1 ]
Campodonico, Jeness [1 ]
Faggiano, Pompilio [2 ]
De Metrio, Monica [1 ]
Rubino, Mara [1 ]
Milazzo, Valentina [1 ]
Sbolli, Marco [2 ]
Perego, Carlotta [2 ]
Provini, Martino [2 ]
Bonomi, Alice [1 ]
Veglia, Fabrizio [1 ]
Bartorelli, Antonio L. [1 ,3 ]
Marenzi, Giancarlo [1 ]
机构
[1] IRCCS, Ctr Cardiol Monzino, Milan, Italy
[2] Univ Brescia, Spedali Civil, Brescia, Italy
[3] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Milan, Italy
关键词
Acute myocardial infarction; PEGASUS-TIMI; 54; Prognosis; Risk score; DUAL-ANTIPLATELET THERAPY; ACUTE CORONARY SYNDROME; CARDIOVASCULAR RISK; TERM; CLOPIDOGREL; VALIDATION; METAANALYSIS; PREDICTORS; TICAGRELOR; DISEASE;
D O I
10.1016/j.ijcard.2018.11.142
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Acute myocardial infarction (AMI) patients are at increased risk of death and recurrent ischemic events. We aimed to elaborate a risk score, based on the PEGASUS-TIMI 54 criteria, to predict mortality and non-fatal AMI in AMI patients. Methods: We retrospectively analyzed two prospectively collected AMI cohorts. We calculated a cut-off for the developed score and investigated its 1-year prognostic power in the derivation cohort (n=1257). We externally validated our score in 913 AMI patients with a longer follow-up. Results: In the derivation cohort, the area under the curve of the score for the primary endpoint (1-year death and non-fatal AMI) was 0.70 (95% CI 0.65-0.76; P < 0.0001) and a cut-off of 6 was identified. The primary endpoint incidence in patients with a score above and below the cut-off was 12% and 3% (P < 0.001) in the derivation cohort and 16% and 6% in the validation cohort (P < 0.001). At multivariate analysis, the HR for the primary endpoint associated with a score >= 6 was 4.45 (P < 0.0001) in the derivation cohort and 2.86 (P < 0.0001) in the validation cohort. One-year major bleeding rate was low (<0.2% overall) and similar between risk groups. The prognostic performance of the score cut-off persisted beyond the first year after AMI in the validation cohort, maintaining a similar risk for death and non-fatal AMI (HR 3) at every following year. Conclusions: Our score, based on the PEGASUS-TIMI 54 criteria, may identify AMI patients at high risk of recurrent ischemic events, who might benefit from thorough preventive strategies. (c) 2018 Elsevier B.V. All rights reserved.
引用
下载
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [1] A NEW SCORE FOR RISK STRATIFICATION OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BASED ON THE PEGASUS-TIMI 54 CRITERIA
    Marenzi, Giancarlo Silvio
    Cosentino, Nicola
    Campodonico, Jeness
    Milazzo, Valentina
    De Metrio, Monica
    Rubino, Mara
    Faggiano, Pompilio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 14 - 14
  • [2] Elaboration and validation of a new score based on the PEGASUS-TIMI 54 criteria for 1-year risk stratification of patients with acute myocardial infarction
    Cosentino, N.
    Campodonico, J.
    Faggiano, P.
    Milazzo, V.
    Rubino, M.
    De Metrio, M.
    Bonomi, A.
    Barbieri, S.
    Marenzi, G.
    EUROPEAN HEART JOURNAL, 2018, 39 : 768 - 768
  • [3] 1-year risk stratification of patients with acute myocardial infarction according to the pegasus-timi 54 criteria
    Cosentino, N.
    Campodonico, J.
    Milazzo, V.
    De Metrio, M.
    Rubino, M.
    Marana, I.
    Moltrasio, M.
    Bonomi, A.
    Faggiano, P.
    Marenzi, G.
    EUROPEAN HEART JOURNAL, 2017, 38 : 784 - 784
  • [4] Prognosis in patients with prior myocardial infarction and PEGASUS-TIMI 54 criteria in the CLARIFY registry
    Biscaglia, S.
    Campo, G.
    Fox, K.
    Tardif, J. C.
    Tendera, M.
    Greenlaw, N.
    Ford, I
    Stanley, B.
    Ferraris, R.
    Steg, P. G.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1431 - 1431
  • [5] Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54
    Bonaca, Marc P.
    Wiviott, Stephen D.
    Morrow, David A.
    Steg, P. Gabriel
    Hamm, Christian
    Bhatt, Deepak L.
    Storey, Robert F.
    Kuder, Julia
    Murphy, Sabina A.
    Magnani, Giulia
    Budaj, Andrej
    Theroux, Pierre
    Nicolau, Jose C.
    Parkhomenko, Alexander
    Lopez-Sendon, Jose
    Dellborg, Mikael
    Diaz, Rafael
    Van de Werf, Frans
    Corbalan, Ramon
    Jensen, Eva C.
    Braunwald, Eugene
    Sabatine, Marc S.
    CIRCULATION, 2015, 132
  • [6] Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54
    Bonaca, Marc P.
    Wiviott, Stephen D.
    Morrow, David A.
    Steg, P. Gabriel
    Hamm, Christian
    Bhatt, Deepak L.
    Storey, Robert F.
    Cohen, Marc
    Kuder, Julia
    Im, KyungAh
    Magnani, Giulia
    Budaj, Andrzej
    Nicolau, Jose C.
    Parkhomenko, Alexander
    Lopez-Sendon, Jose
    Dellborg, Mikael
    Diaz, Rafael
    Van de Werf, Frans
    Corbalan, Ramon
    Goudev, Assen
    Jensen, Eva C.
    Johanson, Per
    Braunwald, Eugene
    Sabatine, Marc S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (22):
  • [7] Clinical benefit of long-term use of dual antiplatelet therapy for acute myocardial infarction patients with the PEGASUS-TIMI 54 criteria
    Lee, Kwan Yong
    Hwang, Byung-Hee
    Choo, Eun-Ho
    Lim, Sungmin
    Kim, Chan Jun
    Kim, Jin-Jin
    Byeon, Jaeho
    Choi, Ik Jun
    Oh, Gyu Chul
    Choi, Yoon Seok
    Yoo, Ki Dong
    Chung, Wook Sung
    Ahn, Youngkeun
    Jeong, Myung Ho
    Chang, Kiyuk
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [8] Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54
    Bhatt, Deepak L.
    Bonaca, Marc P.
    Bansilal, Sameer
    Angiolillo, Dominick J.
    Cohen, Marc
    Storey, Robert F.
    Im, Kyungah
    Murphy, Sabina A.
    Held, Peter
    Braunwald, Eugene
    Sabatine, Marc S.
    Steg, Ph. Gabriel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (23) : 2732 - 2740
  • [9] Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54
    Bonaca, M.
    Jarolim, P.
    Goodrich, E. L.
    Storey, R. F.
    Bhatt, D. L.
    Steg, P. G.
    Cohen, M.
    Jensen, E.
    Johanson, R.
    Braunwald, E.
    Morrow, D. A.
    Sabatine, M. S.
    EUROPEAN HEART JOURNAL, 2017, 38 : 612 - 612
  • [10] Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54
    Parker, William A. E.
    Storey, Robert F.
    HEART, 2016, 102 (10) : 783 - 789